Results 91 to 100 of about 305,335 (274)

PARP inhibitors elicit distinct transcriptional programs in homologous recombination competent castration‐resistant prostate cancer

Molecular Oncology, EarlyView.
PARP inhibitors are used to treat a small subset of prostate cancer patients. These studies reveal that PARP1 activity and expression are different between European American and African American prostate cancer tissue samples. Additionally, different PARP inhibitors cause unique and overlapping transcriptional changes, notably, p53 pathway upregulation.
Moriah L. Cunningham, Jasibel Vasquez‐Gonzalez, Samantha M. Barnada, Salome Tchotorlishvili, Latese Jones, Ryan Maguire, Genevieve Lewis, Kinza Rizwan, Jenny Deng, Salma Koachar, Drithi Patel, Hailey Shankle, Tessa Mulders, Namra Ajmal, Charalambos Solomides, Emad S. Alnemri, Teresa F. Alnemri, Ayesha A. Shafi, Leonard G. Gomella, Wm Kevin Kelly, Steven B. McMahon, Matthew J. Schiewer   +21 more
wiley   +1 more source

From industry 4.0 to lab 4.0

BioTechniques, 2019
Francesca Lake
doaj   +1 more source

What does the UKRI policy mean for open access book publishing?

, 2021
Samuel Moore
openalex   +1 more source

Investigating the cell of origin and novel molecular targets in Merkel cell carcinoma: a historic misnomer

Molecular Oncology, EarlyView.
This study indicates that Merkel cell carcinoma (MCC) does not originate from Merkel cells, and identifies gene, protein & cellular expression of immune‐linked and neuroendocrine markers in primary and metastatic Merkel cell carcinoma (MCC) tumor samples, linked to Merkel cell polyomavirus (MCPyV) status, with enrichment of B‐cell and other immune cell
Richie Jeremian, Sriraam Sivachandran, Melissa Galati, Brandon Ramchatesingh, Hibo Rijal, Johnny Hanna, Elena Netchiporouk, May Chergui, Margaret Redpath, Samy Abou Setah, Ivan V. Litvinov   +10 more
wiley   +1 more source

To blind or not to blind? The search for a perfect peer review methodology

BioTechniques, 2018
Francesca Lake
doaj   +1 more source

The Influence of Open Access on Institutional Scientific Research Output in MENA Countries: A Comparative Analysis

SAGE Open
The release of scientific research has substantial consequences for both the research and the institution in which it was carried out. The selection of publishing methods for scientific articles, such as journal type, quartile, indexed databases, and ...
Marwan Al-Raeei, Chadi Azmeh
doaj   +1 more source

Equitable Open Access Publishing: Changing the Financial Power Dynamics in Academia. [PDF]

Glob Health Sci Pract, 2021
Vervoort D, Ma X, Bookholane H.
europepmc   +1 more source

Misconception about APCs deters an author from publishing open access: A case study

, 2019
Kakoli Majumder
openalex   +1 more source

Integrated genomic and proteomic profiling reveals insights into chemoradiation resistance in cervical cancer

Molecular Oncology, EarlyView.
A comprehensive genomic and proteomic analysis of cervical cancer revealed STK11 and STX3 as a potential biomarkers of chemoradiation resistance. Our study demonstrated EGFR as a therapeutic target, paving the way for precision strategies to overcome treatment failure and the DNA repair pathway as a critical mechanism of resistance.
Janani Sambath, Irene A. George, Srikanth S. Manda, Prasanth Ariyannur, Ekta R. Dhawale, Raja Sekhar Kommu, Rajan Datar, Darshana Patil, Vinita Trivedi, Manisha Singh, Kumar Prabhash, Sewanti Limaye, Richa Chauhan, Prashant Kumar   +13 more
wiley   +1 more source

Join us for the Advancing Precision Medicine BioTechniques Online Symposium

BioTechniques, 2019
Francesca Lake
doaj   +1 more source